Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Aethlon Medical (NQ: AEMD )

2.607 USD -0.043 (-1.61%)
Streaming Delayed Price Updated: 1:34 PM EST, Jan 27, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press releases about Aethlon Medical

< Previous 1 2 3 4 5 6 Next >
Aethlon Medical Expands Leadership Team with Appointment of Chief Business Officer and Chief Medical Officer
Guy Cipriani brings over 17 years of biotech and pharma business development experience to his role as Senior Vice President and Chief Business Officer of Aethlon 
From PR Newswire
Aethlon Medical to Present at the H.C. Wainwright BioConnect 2021 Conference
Aethlon Medical, Inc. (Nasdaq: AEMD), a therapeutic medical device and technology company focused on unmet needs in viral diseases, oncology and inflammation, today announced that the company will... 
From PR Newswire
Aethlon Medical Announces First Patient Treated in First-in-Human Clinical Trial of HEMOPURIFIER® in Head and Neck Cancer
Study is evaluating the HEMOPURIFIER® for reducing cancer-associated exosomes prior to the administration of standard-of-care KEYTRUDA® 
From PR Newswire
Aethlon Announces Appointment of Charles J. Fisher, Jr., M.D. as Chief Executive Officer
Aethlon Medical, Inc. (Nasdaq: AEMD), a medical technology company focused on developing products to diagnose and treat life and organ threatening diseases, announced today the appointment of Charles... 
From PR Newswire
Aethlon Medical Announces Second Quarter Financial Results and Provides Corporate Update
Aethlon Medical, Inc. (Nasdaq: AEMD), a medical device technology company focused on developing products to diagnose and treat life and organ threatening diseases, today reported financial results for... 
From PR Newswire
Aethlon Medical To Release Second Quarter Financial Results and Host Conference Call on October 28, 2020
Aethlon Medical, Inc. (Nasdaq: AEMD), a medical device technology company focused on unmet needs in global health, today announced that it will issue financial results for its second quarter fiscal... 
From PR Newswire
Aethlon Medical to Present at the H.C. Wainwright 22nd Annual Global Investment Conference
Aethlon Medical, Inc. (Nasdaq: AEMD), a medical device technology company focused on developing products to diagnose and treat life and organ threatening diseases, today announced that Timothy C.... 
From PR Newswire
Aethlon Medical to Present at the LD Micro 500 Virtual Conference
Aethlon Medical, Inc. (Nasdaq: AEMD), a medical device technology company focused on developing products to diagnose and treat life and organ threatening diseases, today announced that CEO, Timothy C.... 
From PR Newswire
Aethlon Medical Announces First Quarter Financial Results and Provides Corporate Update
Aethlon Medical, Inc. (Nasdaq: AEMD), a medical device technology company focused on developing products to diagnose and treat life and organ threatening diseases, today reported financial results for... 
From PR Newswire
Aethlon Medical Announces Collaboration with University of Pittsburgh on NIH Grant for Head and Neck Cancer
Up to $3.5 million in funding over 5 years for trials and research at multiple institutions 
From PR Newswire
Aethlon Medical To Release First Quarter Financial Results and Host Conference Call on August 11, 2020
Aethlon Medical, Inc. (Nasdaq: AEMD), a medical device technology company focused on unmet needs in global health, today announced that it will issue financial results for its first quarter fiscal year... 
From PR Newswire
Aethlon Medical Announces Fiscal Year Financial Results and Provides Corporate Update
Aethlon Medical, Inc. (Nasdaq: AEMD), a medical device technology company focused on developing products to diagnose and treat life and organ threatening diseases, today reported financial results for... 
From PR Newswire
Aethlon Medical Presents Hemopurifier® Data at the American Association for Cancer Research 2020 Annual Meeting
The Hemopurifier effectively clears plasma exosomes that originate from diverse types of cancer 
From PR Newswire
Aethlon Announces FDA Approval of IDE Supplement for COVID-19 Patients
Allows for enrollment of up to 40 subjects in up to 20 centers 
From PR Newswire
Aethlon Medical To Release Fourth Quarter Financial Results and Host Conference Call on June 25, 2020
Aethlon Medical, Inc. (Nasdaq: AEMD), a medical device technology company focused on unmet needs in global health, today announced that it will issue financial results for its fourth quarter fiscal... 
From PR Newswire
Aethlon Announces Issuance of European Patent for the Hemopurifier® in Cancer
Corresponding Patents Previously Issued in the United States and Canada 
From PR Newswire
Securities and Exchange Commission (SEC) Order for Halt in trading of Aethlon Medical Stock Expires
Stock to resume trading 
From PR Newswire
Aethlon Medical Announces Third Quarter Financial Results and Provides Corporate Update
Aethlon Medical, Inc. (Nasdaq: AEMD), a medical device technology company focused on developing products to diagnose and treat life and organ threatening diseases, today reported financial results for... 
From PR Newswire
Securities and Exchange Commission (SEC) Order for Halt in trading of Aethlon Medical (NASDAQ:AEMD) Stock
NASDAQ:AEMD) -- On February 7, 2020, the Securities and Exchange Commission (SEC) issued an Order of Suspension of Trading (the "SEC Order"), temporarily suspending trading in Aethlon Medical, Inc.... 
From PR Newswire
Aethlon Medical To Release Third Quarter Financial Results and Host Conference Call on February 10, 2020
Aethlon Medical, Inc. (Nasdaq: AEMD), a medical device technology company focused on unmet needs in global health, today announced that it will issue financial results for its third quarter fiscal year... 
From PR Newswire
Agencies Expect Possible Treatments and Hope for a Coronavirus Vaccine as Soon as Three Months
Tags Featured News
From FinancialNewsMedia.com Newswire for Stock Alerts, Public Company News Alert
Agencies Expect Possible Treatments and Hope for a Coronavirus Vaccine as Soon as Three Months
FN Media Group Presents USA News Group Market Commentary 
From PR Newswire
Several Drugmakers are Racing to Create and Test a Vaccine for China’s Deadly Coronavirus
Tags Featured News
From FinancialNewsMedia.com Newswire for Stock Alerts, Public Company News Alert
Several Drugmakers are Racing to Create and Test a Vaccine for China's Deadly Coronavirus
FN Media Group Presents USA News Group Market Commentary 
From PR Newswire
Agency Taps Australia to Create a Coronavirus Vaccine with ‘Unprecedented Speed’
Tags Featured News
From FinancialNewsMedia.com Newswire for Stock Alerts, Public Company News Alert
Agency Taps Australia to Create a Coronavirus Vaccine With 'Unprecedented Speed'
FN Media Group Presents USA News Group Market Commentary 
From PR Newswire
World Health Organization Accelerating Diagnostics, Vaccines, Therapeutics For Novel Coronavirus
Tags Featured News
From FinancialNewsMedia.com Newswire for Stock Alerts, Public Company News Alert
World Health Organization Accelerating Diagnostics, Vaccines, Therapeutics For Novel Coronavirus
Financialnewsmedia.com News Commentary 
From PR Newswire
Aethlon Medical Announces Completion of $3.77 Million Registered Direct Offering
Aethlon Medical, Inc. (Nasdaq:AEMD) ("Aethlon" or the "Company"), a medical device technology company focused on developing products to diagnose and treat life and organ threatening diseases, today... 
From PR Newswire
Researchers Say Flu Vaccines May Shrink Tumors and Aid in Treating Cancer
FN Media Group Presents USA News Group Market Commentary 
From PR Newswire
< Previous 1 2 3 4 5 6 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.